BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Attia N, Mashal M, Pemminati S, Omole A, Edmondson C, Jones W, Priyadarshini P, Mughal T, Aziz P, Zenick B, Perez A, Lacken M. Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies. Cells 2021;11:116. [PMID: 35011678 DOI: 10.3390/cells11010116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Salerno S, Barresi E, Baglini E, Poggetti V, Da Settimo F, Taliani S. Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents. Molecules 2023;28:2587. [DOI: 10.3390/molecules28062587] [Reference Citation Analysis]
2 Allami P, Heidari A, Rezaei N. The role of cell membrane-coated nanoparticles as a novel treatment approach in glioblastoma. Front Mol Biosci 2022;9:1083645. [PMID: 36660431 DOI: 10.3389/fmolb.2022.1083645] [Reference Citation Analysis]
3 Gisina A, Kholodenko I, Kim Y, Abakumov M, Lupatov A, Yarygin K. Glioma Stem Cells: Novel Data Obtained by Single-Cell Sequencing. Int J Mol Sci 2022;23. [PMID: 36430704 DOI: 10.3390/ijms232214224] [Reference Citation Analysis]
4 Wang G, Wang W. Advanced Cell Therapies for Glioblastoma. Front Immunol 2022;13:904133. [DOI: 10.3389/fimmu.2022.904133] [Reference Citation Analysis]
5 Persano F, Gigli G, Leporatti S. Natural Compounds as Promising Adjuvant Agents in The Treatment of Gliomas. IJMS 2022;23:3360. [DOI: 10.3390/ijms23063360] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]